Crinetics Reports Durable Symptom, Hormone Control With Oral Drug In Acromegaly

benzinga.com/news/health-care/25/07/46401117/crinetics-reports-durable-symptom-hormone-control-with-oral-drug-in-acromegaly

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) on Sunday announced new data from its clinical development program evaluating once-daily, oral investigational palsonify (paltusotine) in acromegaly.
Acromegaly is a rare condition in adults that causes some bones, organs and other tissues to…

This story appeared on benzinga.com, 2025-07-14 18:18:32.
The Entire Business World on a Single Page. Free to Use →